SMART - Servier Medical ART

SMART NEWS

ACTNOWFORDIABETES: Let’s focus on therapeutic adherence

Servier at ASH meeting to present new data in hematology research

Primary Sjögren’s syndrome: completion of patient enrollment in Phase 2a clinical trial

Spartners: Biotech start-up welcome to apply!

Servier and HealthTech For Care, a shared commitment to accelerate therapeutic innovation

Servier unveils its 2030 ambition and reveals a new visual identity